RSS   Newsletter   Contact   Advertise with us
Post Online Media

Organovo Holdings appoints Craig Kussman as CFO

OrganovoOrganovo Holdings, a biotechnology company, announced the appointment of Craig Kussman as chief financial officer from August 22, 2016.

Mr. Kussman was most recently the chief financial officer at Alphaeon Corporation, a lifestyle healthcare company.

Prior to his current role, Kussman served as chief financial officer of XIFIN, a healthcare information technology firm.

Mr. Kussman formerly served as chief financial officer and senior vice president of corporate development for Ascenta Therapeutics, a developmental stage biopharmaceutical company.

He has also held senior executive positions at Breach Security, Discovery Partners International, SYNAVANT, Cognizant, and IMS Health.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy